HLA
TTOO

Hamilton Lane Advisors’s T2 Biosystems, Inc TTOO Stock Holding History

Hamilton Lane Advisors’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-13
Closed -$997K – 74
2015
Q1 		$997K Buy
+13
New +$1.21M 0.45% 28

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HCS
Harvest Capital Strategies San Francisco, California $73.7M AUM 7.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hamilton Lane Advisors's TTOO Position: Q2 2015 in Review

Hamilton Lane Advisors sold out of T2 Biosystems, Inc (TTOO) in Q2 2015, closing a stake of 13 shares — an estimated $997K sold.

Hamilton Lane Advisors first reported a position in TTOO in Q1 2015 and held it in 1 quarter. The position peaked at $997K in Q1 2015. 47 funds tracked by Wall St. Rank hold TTOO as of Q2 2015.

  • Hamilton Lane Advisors reported no remaining T2 Biosystems, Inc position as of Q2 2015 after selling out during the quarter.
  • Hamilton Lane Advisors sold 13 T2 Biosystems, Inc shares in Q2 2015, an estimated $997K.
  • Hamilton Lane Advisors first reported a position in T2 Biosystems, Inc in Q1 2015 and held it in 1 quarter.
  • Hamilton Lane Advisors's T2 Biosystems, Inc position peaked at $997K in Q1 2015.
  • 47 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2015.

Based on Hamilton Lane Advisors's 13F filing for Q2 2015, filed 23 Jul 2015.